WP
IBBQ icon

WealthShield Partners’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

WealthShield Partners’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.9K Hold
100
– – ﹤0.01% 576
2025
Q4 		$2.84K Hold
100
– – ﹤0.01% 545
2025
Q3 		$2.43K Hold
100
– – ﹤0.01% 548
2025
Q2 		$2.11K Hold
100
– – ﹤0.01% 542
2025
Q1 		$2.12K Hold
100
– – ﹤0.01% 523
2024
Q4 		$2.15K Hold
100
– – ﹤0.01% 480
2024
Q3 		$2.38K Hold
100
– – ﹤0.01% 477
2024
Q2 		$2.28K Hold
100
– – ﹤0.01% 455
2024
Q1 		$2.22K Buy
+100
New +$2.22K ﹤0.01% 463

Other funds holding IBBQ

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

WealthShield Partners's IBBQ Position: Q1 2026 in Review

WealthShield Partners held its Invesco NASDAQ Biotechnology ETF (IBBQ) position steady in Q1 2026 at 100 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #576.

WealthShield Partners first reported a position in IBBQ in Q1 2024 and has held it in 9 quarters since. 40 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • WealthShield Partners held 100 shares of Invesco NASDAQ Biotechnology ETF worth $2.9K as of Q1 2026.
  • WealthShield Partners left its Invesco NASDAQ Biotechnology ETF share count unchanged in Q1 2026.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of WealthShield Partners's portfolio in Q1 2026, its #576 holding.
  • WealthShield Partners first reported a position in Invesco NASDAQ Biotechnology ETF in Q1 2024 and has held it in 9 quarters since.
  • 40 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.